Documents to download

Biological ageing results from the accumulation of damage within cells, leading to a loss of function and, ultimately, cell death.  The underlying mechanisms of ageing are also risk factors in the onset of frailty, disability and long-term disease. This POSTnote examines the biological basis of ageing, the potential to manipulate the ageing process and to use such knowledge to promote better health later in life.

Acknowledgements

POSTnotes are based on literature reviews and interviews with
a range of stakeholders and are externally peer reviewed.
POST would like to thank interviewees and peer reviewers
for kindly giving up their time during the preparation

Dr Aoife Kidy (Alzheimer’s Society)
Dr Mathew Norton (Alzheimer’s Research UK)
Professor Wolf Reik (Babraham Institute)
Dr Jon Houseley (Babraham Institute)
Dame Linda Partridge (University College London)
Professor Lynne Cox (University of Oxford)
Catherine Joynson (Nuffield Council of Bioethics)
Professor Diana Kuh (University College London)
Professor Martin Knapp (London School of Economics)
Professor Mark Hanson (University of Southampton)
Gareth Giles (University of Southampton)
Dr Chandni Jacobs (University of Southampton)
Professor Thomas Von Zglinicki (Newcastle University)
Professor John Mathers (Newcastle University)
Professor Thomas Kirkwood (Newcastle University)
Dr João Pedro de Magalhães (Univesity of Liverpool)
Dr Alison Tedstone (Public Health England)


Documents to download

Related posts

  • The COVID-19 Winter Plan, published 23 November, relies on three factors to provide the UK with a “route back to normality”: vaccines, treatments and testing. In addition to PCR testing, lateral flow devices are now being rolled out across England and Wales for the rapid testing of certain occupational groups, community testing and as an alternative to self-isolation following exposure to the virus. How well validated have these tests been? Are they accurate enough for their proposed purposes? And how have they performed to date in mass testing trials?

  • People’s behaviour has a major role in the success of test, trace and isolate programmes. Uncertainty about whether to report symptoms, low perceived risk of COVID-19 disease and concerns about the consequences of self-isolation are among the barriers to adherence. Has the Scientific Advisory Group for Emergencies looked at adherence to TTI? What evidence is there on people’s understanding and willingness to be tested, provide contact details and self-isolate? Is there anything that can be done to improve this?